| Latest | F'cast | |
|---|---|---|
| Div Yield | 1.7% | 1.8% |
| Div Cover | 3.4 | 3.2 |
| Op Mrgn | 12.2% | 12.6% |
| ROCE | 18.5% |
| Latest | F'cast | |
|---|---|---|
| P/E | 18.0 | 16.9 |
| PEG | 1.4 | 2.8 |
| Pr/Revenue | 2.0 | 1.7 |
| Pr/Book | 2.2 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 8.6% | 17.1% |
| PBT | -11.6% | 42.0% |
| EPS | 12.7% | 6.1% |
| DPS | 13.6% | 9.8% |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Mar-08 | 225.00 | 18.85 | 35.46p | 18.1 | 0.9 | +21% | 10.10p | 1.6% |
| 29-Mar-09 | 274.10 | 16.33 | 37.10p | 8.6 | 1.7 | +5% | 11.00p | 3.4% |
| 28-Mar-10 | 286.42 | 24.53 | 45.74p | 13.6 | 0.6 | +23% | 13.20p | 2.1% |
| 03-Apr-11 | 287.31 | 36.73 | 53.54p | 15.4 | 0.9 | +17% | 15.84p | 1.9% |
| 01-Apr-12 | 311.95 | 32.48 | 60.32p | 14.1 | 1.1 | +13% | 18.00p | 2.1% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Mar-13 | 365.37 | 46.13 | 64.01p | 16.9 | 2.8 | +6% | 19.76p | 1.8% |
| 31-Mar-14 | 406.75 | 53.47 | 71.33p | 15.2 | 1.3 | +11% | 21.99p | 2.0% |
| 31-Mar-15 | 431.61 | 59.53 | 78.16p | 13.9 | 1.5 | +10% | 24.32p | 2.2% |
Copyright © 2013 FactSet Research Systems Inc. All rights reserved.
| Trading Statement | 18-Apr-2013 | 07:00 | RNS |
| Holding(s) in Company | 16-Apr-2013 | 16:38 | RNS |
| Total Voting Rights | 02-Apr-2013 | 07:00 | RNS |
| Thursday broker round-up UPDATE | 18-Apr-2013 | ShareCast |
| London pre-open: Modest rise forecast for FTSE | 18-Apr-2013 | ShareCast |
| Synergy Health reports 'robust' fourth quarter t... | 18-Apr-2013 | ShareCast |
| Synergy launches NHS superbug screening | 13-May-2007 | Observer |
| Secret talks row in Isotron takeover | 26-Nov-2006 | Sunday Times |
| Synergy offers £143m for Isotron | 26-Oct-2006 | Times |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 1,074.00p |
| Change Today | -10.00p |
| % Change | -0.92 % |
| 52 Week High | 1,118.00 |
| 52 Week Low | 779.00 |
| Volume | 2,446 |
| Shares Issued | 58.52m |
| Market Cap | £628.50m |
| Beta | 0.43 |
| RiskGrade | 84 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 3 |
| Buy | 1 |
| Neutral | 3 |
| Sell | 0 |
| Strong Sell | 1 |
| Total | 8 |

| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 21-Nov-12 | 08-Aug-12 |
| Paid | 14-Dec-12 | 06-Sep-12 |
| Amount | 7.90p | 11.18p |
| Time | Volume / Share Price |
| 11:00 | 26 @ 1,074.00p |
| 11:00 | 119 @ 1,074.00p |
| 10:30 | 6 @ 1,074.00p |
| 10:10 | 59 @ 1,078.00p |
| 09:54 | 81 @ 1,080.00p |
| CEO | Dr Richard M Steeves |
| Finance Director | Gavin Hill |
| Chair | Duncan K Nichol |
You are here: research